Peripheral Perfusion Index as an Early Predictor of Successful Caudal Block in Pediatric Patients Undergoing Lower Abdominopelvic Surgeries Under General Anesthesia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-5
SponsorAin Shams University

About this trial

The aim of this study is to assess early predictability of peripheral perfusion index to success of caudal block in pediatric patients undergoing lower abdominopelvic surgeries

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pediatric patients aging between 1-5 years of both sexes.

Pediatric patients posted for elective lower abdominopelvic surgeries under general anesthesia (duration of surgery under 120 minutes).

ASA physical status classes I - II.

Disqualifiers

Guardian's refusal of procedure or participation in the study.

ASA classes III or above.

Infection at site of injection.

Neurological diseases and disorders such as (neuromuscular disease, cerebral palsy, spinal dysraphism …etc.)

Trial population

All pediatric patients undergoing elective lower abdominopelvic surgeries under general anesthesia at El-Demerdash Pediatric Surgery Hospital during the study period. Surgeries include inguinal / inguinoscrotal hernia repair, hydrocelectomy, orchiopexy.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Peripheral perfusion index pulse oximeter

    Device

    Masimo pulse oximeter probe for measuring peripheral perfusion index and predicting success of caudal block

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

peripheral perfusion index predictability

Monitor and compare peripheral perfusion index values before and after administration of the caudal block to determine if there is a significant correlation between early PPI changes and the success of caudal block

Time frame
From enrollment to discharge from post anesthesia care unit

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.